Introduction
Drug offences by healthcare professionals in Turkey are treated with particular seriousness because doctors, dentists, pharmacists, nurses, chemists, laboratory workers and other healthcare-related professionals may have professional access to medicines, controlled substances, prescription systems, laboratory materials and pharmaceutical distribution channels. Turkish criminal law therefore contains aggravated penalty rules where certain drug offences are committed by persons who hold healthcare, pharmaceutical or chemical professional status.
The main provision is Article 188 of the Turkish Penal Code, which regulates drug manufacturing and trafficking. Article 188 punishes unlawful manufacturing, importation or exportation of narcotic or stimulant substances with imprisonment from twenty to thirty years and a judicial fine from 2,000 days to 20,000 days. It also punishes domestic acts such as selling, offering for sale, giving to others, dispatching, transporting, storing, purchasing, accepting or possessing narcotic or stimulant substances for trafficking purposes with imprisonment of not less than ten years and a judicial fine from 1,000 days to 20,000 days.
For healthcare professionals, the most important rule is Article 188/8. This provision states that if the offences defined in Article 188 are committed by a physician, dentist, pharmacist, chemist, veterinarian, health officer, laboratory worker, midwife, nurse, dental technician, caregiver, person providing health services, or a person engaged in chemistry or pharmaceutical trade, the sentence is increased by half.
A second important provision is Article 190, which regulates facilitating drug use. Article 190 punishes providing a special place, equipment or materials for drug use, taking measures to prevent users from being caught, giving information about methods of use, and publicly encouraging drug use. Article 190 also contains a professional aggravation rule: if the offence is committed by the same listed healthcare, chemical or pharmaceutical professionals, the sentence is increased by half.
1. Why Healthcare Professionals Face Aggravated Liability
Healthcare professionals are not punished more severely merely because of their social status. The aggravated rule exists because their profession may give them access, knowledge and authority that can make drug-related offences easier, more dangerous and more difficult to detect.
A physician may have access to prescription systems and medical reports. A pharmacist may have access to controlled medicines and pharmaceutical stock records. A nurse or health officer may have access to medication storage areas. A chemist or laboratory worker may understand chemical substances, production methods or precursor materials. A person engaged in pharmaceutical trade may have access to supply chains, invoices, warehouses and distribution systems.
This professional position creates a higher duty of care. When such a professional uses that position to commit drug trafficking, unlawful supply, storage, prescription abuse or facilitation of drug use, Turkish law treats the conduct as more blameworthy.
However, the aggravation must still be applied carefully. A healthcare title alone is not enough. The prosecution must prove the underlying offence under Article 188 or Article 190, and then prove that the accused falls within one of the listed professional categories.
2. Article 188/8: The Professional Aggravation Rule
Article 188/8 is a sentence-increasing provision. It does not create a separate offence by itself. First, the prosecution must prove one of the Article 188 offences. These include manufacturing, importation, exportation, sale, offering for sale, supplying, giving to others, dispatching, transporting, storing, purchasing, accepting or possessing narcotic or stimulant substances for trafficking purposes. Only after the basic Article 188 offence is proven can the court apply the professional aggravation rule.
The listed professionals under Article 188/8 include:
Physicians; dentists; pharmacists; chemists; veterinarians; health officers; laboratory workers; midwives; nurses; dental technicians; caregivers; persons providing health services; and persons engaged in chemistry or pharmaceutical trade.
The effect is severe: the sentence is increased by half. If the base penalty is already high, the final sentence may become extremely serious. For example, if a pharmacist is convicted of storing controlled narcotic substances for trafficking purposes, the court may first determine the Article 188/3 penalty and then increase it by half under Article 188/8 if the legal conditions are met.
3. Article 188/6: Prescription-Based Substances and Controlled Medicines
Article 188/6 is particularly important in healthcare cases. It provides that Article 188 rules also apply to substances whose production is subject to official permission or whose sale depends on a prescription issued by an authorized physician, if those substances create narcotic or stimulant effects. However, the sentence may be reduced by up to half.
This provision is highly relevant to prescription drug offences. A medicine may be legally produced, stored or sold within the healthcare system, but it may become a criminal-law issue if it is diverted, sold unlawfully, supplied without legal basis, prescribed falsely, stored outside authorized channels, or used for non-medical narcotic or stimulant purposes.
Examples may include:
Prescription opioids; narcotic painkillers; stimulant medications; psychotropic medicines; sedatives; controlled psychiatric medication; medicines used in addiction treatment; and substances whose lawful circulation depends on medical authorization.
The defence must carefully distinguish lawful medical practice from unlawful diversion. A doctor prescribing medication for a genuine medical indication should not be treated the same as a person issuing false prescriptions for unlawful distribution. A pharmacist dispensing medicine according to a valid prescription should not be treated the same as a pharmacist selling controlled medicines without legal basis.
4. Article 190/3: Facilitating Drug Use by Healthcare Professionals
Article 190 regulates facilitating drug use. The basic offence includes providing a special place, equipment or materials for drug use, taking measures to make users harder to catch, or giving information about drug-use methods. The punishment is imprisonment from five to ten years and a judicial fine from 1,000 days to 10,000 days. Publicly encouraging drug use or publishing content of that nature is also punished within the same range.
Article 190/3 states that if these offences are committed by the listed professionals, including doctors, dentists, pharmacists, chemists, veterinarians, health officers, laboratory workers, midwives, nurses, dental technicians, caregivers, healthcare service providers, and persons engaged in chemistry or pharmaceutical trade, the sentence is increased by half.
This may apply where a healthcare professional does not directly sell or supply the drug, but facilitates use. For example, a professional who provides equipment, gives practical use instructions, arranges a safe place for unlawful use, or uses medical knowledge to make drug consumption easier may face Article 190 liability.
However, Article 190 must not be applied mechanically. The law requires a specific facilitating purpose. Case-law summaries on Article 190 emphasize that merely using drugs together, without the special intent to facilitate another person’s use through a legally defined act, does not automatically constitute Article 190.
5. Difference Between Article 188 and Article 190
The distinction between Article 188 and Article 190 is essential. Article 188 concerns drug trafficking, manufacturing, importation, exportation, sale, supply, transportation, storage and possession for trafficking purposes. Article 190 concerns facilitating another person’s use without necessarily supplying the drug itself.
If a healthcare professional gives, sells or supplies a narcotic or stimulant substance to another person, Article 188 may apply. If the professional does not supply the substance but provides equipment, special place, protective measures or instructions to facilitate use, Article 190 may apply. Article 190 materials also clarify that providing the drug itself should not be confused with merely providing place, equipment or other facilitative support.
This distinction matters because misclassification can affect penalty, defence strategy and legal outcome. A doctor who unlawfully supplies narcotic medication may face Article 188. A healthcare worker who explains unlawful use methods or provides equipment for consumption may face Article 190. A person who only participates in personal use may fall outside Article 190 if the special facilitating intent and act are absent.
6. Doctors and Drug Offences in Turkey
Doctors may face criminal risk in drug cases where prescriptions, medical reports or treatment authority are misused. The most common risk areas include false prescriptions, medically unnecessary prescriptions, repeated prescriptions without examination, prescription of controlled substances for non-medical purposes, cooperation with patients or third parties to obtain narcotic-effect medicines, and use of medical authority to support unlawful drug circulation.
However, criminal liability cannot be based merely on a bad medical decision or later disagreement with treatment. The prosecution must prove intentional conduct. A doctor who makes a medical judgment in good faith should not be treated as a trafficker simply because the prescribed medicine later becomes misused by the patient.
Key defence questions include:
Was there a genuine patient relationship? Was the patient examined? Was there a medical indication? Was the prescription consistent with diagnosis and treatment guidelines? Were quantities medically reasonable? Was there any payment beyond ordinary medical service? Did the doctor know the medicine would be abused or resold? Did the doctor act as part of a drug distribution chain?
The distinction between malpractice, disciplinary misconduct and criminal drug trafficking must be carefully maintained.
7. Pharmacists and Controlled Medicine Offences
Pharmacists are particularly exposed to drug-law risks because they handle medicines, prescriptions, stock records, controlled storage and patient dispensing. A pharmacist may face Article 188 allegations if they unlawfully sell or supply controlled medicines, dispense narcotic-effect medicines without valid prescriptions, falsify records, cooperate with false prescriptions, or divert stock outside lawful channels.
Pharmacy cases are document-heavy. The prosecution may rely on prescription records, stock movement, invoices, patient data, camera footage, witness statements, digital communications and inspection reports. The defence should examine whether the prescriptions were valid on their face, whether the pharmacist had reason to suspect abuse, whether the medicine was lawfully supplied, whether stock discrepancies have administrative explanations, and whether the accused personally participated.
Not every irregularity in pharmacy records proves drug trafficking. Some issues may be administrative, technical, accounting-related or caused by staff error. Article 188 requires criminal intent and trafficking-related conduct.
8. Nurses, Health Officers and Caregivers
Nurses, health officers and caregivers may have access to medicine storage rooms, patient medication, controlled hospital stocks or treatment materials. Criminal risk may arise where such persons remove medication from a hospital, supply controlled substances to third parties, falsify administration records, help patients misuse drugs, or provide equipment or instructions for unlawful use.
The defence must examine access and responsibility. Was the accused the person responsible for the medication? Were several staff members able to access the same storage area? Were hospital stock records accurate? Was the medicine actually missing? Is there camera footage? Is there a witness statement? Did the accused have intent to supply or use unlawfully?
Healthcare workplaces often involve shared access. A nurse should not be held criminally responsible solely because a medicine was missing from a unit accessible to many employees. The prosecution must prove individual participation.
9. Chemists, Laboratory Workers and Precursor Materials
Chemists and laboratory workers may face serious allegations in cases involving synthetic drugs, chemical production, precursor substances or laboratory equipment. Article 188/7 separately punishes certain substances that do not themselves produce narcotic or stimulant effects but are used in producing such substances and whose importation or manufacturing is subject to official permission. The penalty is imprisonment of not less than eight years and a judicial fine from 1,000 days to 20,000 days.
This is particularly relevant to professionals with chemical knowledge. A chemist may be accused of producing synthetic substances, supplying precursor chemicals, storing controlled chemicals, or advising others about production. A laboratory worker may be accused of misusing access to equipment or chemical materials.
However, lawful scientific, industrial, pharmaceutical or educational work must not be confused with criminal production. The prosecution must prove unlawful purpose, knowledge and connection to drug production. The defence should examine permits, invoices, laboratory records, research purpose, storage logs, institutional authorization and whether the substance is legally controlled.
10. Veterinarians and Veterinary Medicines
Veterinarians are listed in Article 188/8 and Article 190/3. Veterinary medicine may involve controlled substances, sedatives, anesthetics and medicines with abuse potential. Criminal liability may arise if veterinary substances are diverted for human use, sold unlawfully, prescribed falsely, or stored outside lawful channels for trafficking purposes.
Defence in veterinary drug cases should focus on professional necessity, animal treatment records, prescription or administration records, stock logs, patient files, farm or clinic documentation, and whether the medicine was used for genuine veterinary purposes.
As with doctors, criminal liability requires more than professional irregularity. The prosecution must prove intentional unlawful conduct connected with narcotic or stimulant effects.
11. Healthcare Professionals and Personal Use
A healthcare professional may also be accused of personal drug use or possession for personal consumption. In such cases, Article 191 may be relevant rather than Article 188 or Article 190. Article 191 regulates purchasing, accepting, possessing or using narcotic or stimulant substances for personal use and generally operates through postponed prosecution, probation and treatment-oriented measures.
Professional status does not automatically transform a personal-use case into trafficking. If a nurse, doctor, pharmacist or laboratory worker possesses a small quantity for personal consumption and there is no sale, supply, storage, distribution or facilitation evidence, Article 191 may be the correct classification.
However, professional access may create suspicion. The prosecution may ask whether the substance came from workplace stock, whether prescriptions were abused, whether others were supplied, or whether professional records were manipulated. The defence should separate personal-use evidence from trafficking allegations.
12. Professional Status Alone Is Not Enough
A crucial defence principle is that professional status alone does not prove aggravated drug liability. Article 188/8 and Article 190/3 apply only if the underlying offence is proven. The court must first determine whether the accused committed Article 188 or Article 190. Only then can the professional aggravation increase the sentence.
For example, a doctor present in a room where others use drugs does not automatically commit Article 190. A pharmacist whose name appears in pharmacy records does not automatically commit Article 188. A nurse working in a hospital unit where medication is missing does not automatically become responsible for unlawful storage or supply.
The prosecution must prove:
The exact offence; the accused’s act; the accused’s intent; the substance’s legal nature; professional status; and the connection between the accused and the criminal conduct.
This individualized proof is essential because Turkish criminal law does not allow punishment by title, profession or assumption.
13. Prescription Abuse and False Prescriptions
Prescription abuse is one of the most common areas where healthcare professionals may face drug offence allegations. A false prescription may be used to obtain controlled medication, narcotic painkillers, stimulant medicines or psychotropic substances. The doctor, pharmacist, patient and intermediaries may all be investigated depending on the facts.
The prosecution may allege that the doctor issued prescriptions without medical need, that the pharmacist knowingly dispensed controlled medicines unlawfully, or that patients were used as nominal recipients. Evidence may include prescription frequency, patient identity, diagnosis records, dosage, pharmacy dispensing records, camera footage, payment patterns and digital messages.
The defence should ask:
Were patients real? Were examinations performed? Were prescriptions medically justified? Were quantities consistent with treatment? Did the pharmacist have reason to question the prescription? Were official systems used? Were signatures authentic? Were records manipulated by another person?
False prescription cases require both medical and criminal analysis. Expert medical opinion may be necessary.
14. Evidence in Healthcare Professional Drug Cases
Healthcare drug cases are usually evidence-intensive. Common evidence includes:
Prescription records; pharmacy stock logs; hospital medication records; laboratory inventory; inspection reports; forensic substance analysis; toxicology reports; camera footage; witness statements; patient statements; digital messages; phone records; invoices; cargo records; professional registration documents; and expert reports.
The defence should not evaluate these records superficially. Medical and pharmaceutical records can be complex. Apparent irregularities may have lawful explanations: emergency prescribing, system errors, stock reconciliation delays, substitution rules, patient non-compliance, documentation mistakes, staff access or institutional workflow.
A strong defence often requires comparing criminal evidence with professional practice standards.
15. Forensic Reports and Substance Classification
Forensic analysis is central. The prosecution must prove that the relevant material is a narcotic or stimulant substance, a prescription substance producing narcotic or stimulant effects, or a precursor-type substance covered by Article 188/7. Article 188 includes specific rules for narcotic/stimulant substances, prescription-dependent substances producing such effects, and precursor materials used in production.
A forensic report may prove the substance type, but it does not prove intent. It does not prove that a doctor prescribed unlawfully, a pharmacist sold unlawfully, or a nurse diverted medicine. The defence should examine whether the report identifies the active ingredient, quantity, legal classification, sample integrity and chain of custody.
Where the substance is a lawful medicine, the legal question is more complex: was it used within lawful medical circulation or diverted unlawfully?
16. Digital Evidence in Professional Drug Cases
Digital evidence may include WhatsApp messages with patients, pharmacy communications, prescription images, hospital system logs, stock movement records, e-mails, call records, camera footage and electronic prescription data.
Digital evidence can be powerful, but it can also be misunderstood. A message about “medicine,” “prescription,” “dose,” or “stock” may be medically ordinary rather than criminal. A pharmacist’s communication with a patient may be lawful. A doctor’s treatment instruction may be misinterpreted if removed from medical context.
The defence should request full conversation records, system logs, user access data, authentication of screenshots, and expert review where necessary. It should also examine whether digital searches were lawful and whether privileged or unrelated medical data was improperly accessed.
17. Disciplinary Liability vs. Criminal Liability
Healthcare professionals may face professional disciplinary proceedings, administrative sanctions and criminal proceedings at the same time. These should not be confused.
A prescription error may lead to disciplinary review but not necessarily criminal drug trafficking. A pharmacy stock discrepancy may lead to administrative inspection but not necessarily Article 188. A hospital medication documentation failure may be professional negligence but not intentional supply of narcotics.
Criminal liability requires proof beyond administrative irregularity. The prosecution must prove intent and the legal elements of Article 188 or Article 190. The defence should clearly separate:
Medical malpractice; professional negligence; disciplinary misconduct; administrative regulation breach; and intentional drug offence.
This distinction is essential for preventing professional mistakes from being wrongly escalated into aggravated criminal liability.
18. Search and Seizure in Clinics, Pharmacies and Hospitals
Drug investigations involving healthcare professionals may include searches in clinics, pharmacies, laboratories, warehouses, hospitals or private offices. Search and seizure records may involve medicines, prescriptions, computers, patient files and stock logs.
The defence should examine the legality and scope of the search. Was there a valid search order? Did it identify the correct place? Were only relevant materials seized? Were patient confidentiality and professional data protected? Were medicines sealed and counted properly? Does the forensic report match the seizure record?
In healthcare settings, overbroad searches may create privacy and confidentiality problems. Criminal investigation must be balanced with protection of patient data and professional records.
19. Pre-Trial Detention Risk
Healthcare professionals accused under Article 188 may face pre-trial detention because Article 188 carries severe penalties. However, detention is not automatic. The defence may argue that the accused has a fixed address, professional identity, family ties, no flight risk, and that evidence is mainly documentary and already collected.
Judicial control may be proposed instead of detention. Measures may include travel ban, signature obligation, prohibition on contacting certain persons, temporary restrictions related to workplace access, or surrender of passport.
The defence should also argue correct classification. If the matter concerns administrative prescription irregularities or personal use rather than trafficking, detention may be disproportionate.
20. Defence Strategies for Healthcare Professionals
A strong defence strategy should be built around the specific profession, substance and allegation. Common defence arguments include:
The prescription was medically justified.
The medicine was dispensed according to a valid prescription.
The accused did not know the substance would be misused.
The accused had no intent to traffic or facilitate use.
The act is administrative or disciplinary, not criminal.
Stock discrepancy has a lawful explanation.
Others had access to the medicine or system.
Digital messages are medical in context.
The forensic report does not prove unlawful supply.
Professional aggravation cannot apply because the underlying offence is not proven.
Article 191 personal use applies, not Article 188 trafficking.
Article 190 special facilitation intent is absent.
Search and seizure were unlawful or overbroad.
Expert medical or pharmaceutical review is required.
The defence should also request expert examination where the case turns on medical necessity, prescription practice, pharmacy procedure or chemical classification.
21. Practical Checklist for Lawyers
A lawyer handling a drug offence case involving a healthcare professional should ask:
What exact offence is alleged: Article 188, Article 190 or Article 191?
What is the accused’s professional status?
Is the professional status listed in Article 188/8 or Article 190/3?
Was the underlying offence proven?
What substance is involved?
Is it a narcotic, stimulant, prescription-dependent substance or precursor?
Was there lawful medical indication?
Were prescriptions valid?
Were pharmacy or hospital records complete?
Who had access to stock, systems or storage?
Is there evidence of sale, supply or trafficking?
Is there evidence of facilitation under Article 190?
Was the conduct merely personal use?
Were digital messages interpreted in medical context?
Was the search lawful?
Was patient confidentiality protected?
Is expert medical, pharmaceutical or chemical analysis needed?
Can disciplinary liability be separated from criminal liability?
Is detention proportionate?
This checklist helps prevent automatic application of aggravated professional liability.
Frequently Asked Questions
Are healthcare professionals punished more severely for drug trafficking in Turkey?
Yes. Under Article 188/8 of the Turkish Penal Code, if Article 188 drug manufacturing or trafficking offences are committed by listed healthcare, chemical or pharmaceutical professionals, the sentence is increased by half.
Which professionals are covered by Article 188/8?
The list includes physicians, dentists, pharmacists, chemists, veterinarians, health officers, laboratory workers, midwives, nurses, dental technicians, caregivers, persons providing health services, and persons engaged in chemistry or pharmaceutical trade.
Can prescription medicines lead to Article 188 liability?
Yes. Article 188/6 states that Article 188 rules may apply to substances whose production is subject to official permission or whose sale depends on a prescription issued by an authorized physician, if they produce narcotic or stimulant effects.
Does a prescription mistake automatically mean drug trafficking?
No. A prescription error, record irregularity or professional mistake does not automatically prove Article 188. The prosecution must prove intentional unlawful conduct and the elements of the drug offence.
Can healthcare professionals be punished for facilitating drug use?
Yes. Article 190 punishes facilitating drug use, and Article 190/3 increases the sentence by half if the offence is committed by listed healthcare, chemical or pharmaceutical professionals.
Is personal drug use by a healthcare professional treated as trafficking?
Not automatically. If the facts show personal use only and there is no sale, supply, storage, distribution or facilitation evidence, Article 191 may be more appropriate than Article 188 or Article 190.
Conclusion
Drug offences by healthcare professionals in Turkey create aggravated criminal liability because medical, pharmaceutical and chemical professions involve special access, trust and technical knowledge. Article 188/8 increases the penalty by half when drug manufacturing or trafficking offences are committed by listed professionals. Article 190/3 similarly increases the penalty where facilitating drug use is committed by such professionals.
However, aggravated professional liability must be applied carefully. A person’s professional title is not enough. The prosecution must first prove the underlying offence under Article 188 or Article 190. It must then prove that the accused falls within the listed professional categories and intentionally committed the relevant act.
Healthcare drug cases often involve prescription records, controlled medicines, pharmacy stock, laboratory materials, hospital access, digital messages and professional documentation. These records must be interpreted in medical and pharmaceutical context. Not every prescription error, stock discrepancy, treatment disagreement or administrative irregularity is a criminal drug offence.
A strong defence should separate lawful medical practice, professional negligence, disciplinary liability, personal use and intentional drug trafficking. It should examine medical indication, prescription validity, pharmacy procedure, access logs, stock records, forensic reports, digital evidence, search legality and expert opinions. Where the evidence proves only personal use, Article 191 should be considered. Where Article 190 special facilitation intent is absent, that charge should be challenged. Where Article 188 trafficking intent is not proven, aggravated professional punishment should not apply.
In Turkish criminal law, healthcare professionals face serious risks in drug-related investigations, but liability must still be based on lawful, reliable and individualized evidence.
Yanıt yok